http://www.chemistrymag.org/cji/2004/064028ne.htm |
Apr. 18,
2004 Vol.6 No.4 P.28 Copyright |
The antiviral activities on HSV-1 and CVB3 in vitro of polysaccharide from alga eucheuma striatu
Cen Yingzhou1, Khoo Gaikming1, Ye Shaoming1, Wang Yifei
2Received Dec.31, 2003; Supported by the National Natural Science Foundation of China (No. 20172020), Foundation of Important Technological Items of Guangdong Province, China (2002A3050503), Natural Science Foundation of Guangdong Province, China (2001-10-010401, 2003£11)
Abstract To assay the antiviral
activities on HSV-1 and CVB3 in vitro of the polysaccharide from Eucheuma
striatum, and its antiviral mechanism was explored. Vero cells were infected by HSV-1
and CVB3, and they were cultured with serial dilutions of polysaccharide. The
cells cytotoxicity of polysaccharide was evaluated by the MTT method. The inhibitory
effects were evaluated by the cytopathic effect (CPE). Its antiviral mechanism was studied
by the method of giving samples in different time. The polysaccharide could inhibit the
CPE of cells infected by HSV-1 and CVB3. It showed low cytotoxicity on Vero
cells. Its antiviral activities were better than Acyclovir and ribavirin which were run in
parallel as the positive control samples. The polysaccharide from Eucheuma striatum
has potent antiviral activities. Its antiviral mechanism is that it can prevent the virus
from absorbing to the cell surface. Such research work has not ever been reported before.
Keywords Polysaccharide , Eucheuma striatum, herpes simplex virus type-1, Coxsackie
virus B3
Concentration of ESP ( mg/mL) |
OD ( x¡Às) |
Viability of cell (%) |
4000.00 |
0.277 ¡À0.008 |
64.19* |
2000.00 |
0.300 ¡À0.007 |
78.97* |
1000.00 |
0.314 ¡À0.015 |
82.86* |
500.00 |
0.332 ¡À0.006 |
87.54* |
250.00 |
0.336 ¡À0.009 |
88.53* |
125.00 |
0.335 ¡À0.038 |
88.40* |
62.50 |
0.341 ¡À0.015 |
89.98* |
31.25 |
0.349 ¡À0.016 |
92.08 |
Control |
0.379 ¡À0.010 |
100.00 |
2.2 Antiviral assays of ESP against HSV-1 and
CVB3
Table 2 Antiviral activity of ESP against HSV-1
Methods |
ACV |
ESP |
||||
CC50 |
IC50 |
SI |
CC50 |
IC50 |
SI |
|
Pre-treatment to Vero cells |
4000 |
100.00 |
40 |
>4000 |
1.56 |
>2564 |
Effects on viral growth |
4000 |
200.00 |
20 |
>4000 |
50.00 |
>80 |
Direct effects on virus |
4000 |
6.25 |
640 |
>4000 |
3.12 |
>1282 |
Virus binding |
4000 |
100.00 |
40 |
>4000 |
3.12 |
>1282 |
Table 3 Antiviral activity of ESP against CVB3
mg/mLMethods |
Ribavirin |
ESP |
||||
CC50 |
IC50 |
SI |
CC50 |
IC50 |
SI |
|
Pre-treatment to Vero cells |
4900 |
39.06 |
125 |
>4000 |
0.16 |
>25000 |
Effects on viral growth |
4900 |
39.06 |
125 |
>4000 |
10.00 |
>400 |
Direct effect on virus |
4900 |
156.25 |
31 |
>4000 |
0.62 |
>6451 |
Virus binding |
4900 |
78.13 |
63 |
>4000 |
0.16 |
>25000 |
2.3 Discussion
Monoherpes virus belongs to the a-herpes virus family. Herpes
infections are ubiquitous. HSV-1 is normally associated with orofacial infections,
keratitis and encephalitis. Acyclovir(ACV) is a common drugs used to treat
herpes-infection at present but acyclovir-resistant HSV infections have emerged because of
the increase in drug use frequency. Coxsackie virus is a member of the enterovirus genus of the picornavirus family. Coxsackie virus group B especially CVB3
is regarded as the most common agent of viral myocarditis and are also capable to induce a
chronic myocarditis associated with a persistent type of heart muscle infection. Coxsackie
virus infects humans year-round, especially causing high mortality among the newborns. No
compounds have yet been found that are clinically effective against the Coxsackie virus
diseases. Thus, there is an urgent need for novel anti-Coxsackie agents.
In this
study, the antiviral activity in vitro of the ESP was described. The results showed that
ESP could inhibit the CPE of cells infected by HSV-1 and CVB3 in certain concentration
range. Furthermore, it showed low cytotoxicity to the normal Vero cells. Its antiviral
activities were better than Acyclovir and Ribavirin which were run in parallel as positive
control samples. The results suggested that the polysaccharide from Eucheuma striatum
may be a potential anti-HSV and anti-Coxsackie virus drug candidates.
The antiviral mechanism was studied through three methods. Firstly, the
effects of pre-treatment by ESP on Vero cells, to observe the ability of ESP protecting
Vero cells from attacking by the virus. Secondly, the inhibition effects of ESP to
virus-infected cells, to observe whether this polysaccharide was able to inhibit the
biosynthesis or release of viruses. Thirdly, the direct inactivation effects of
polysaccharide to the virus. The results showed that the antiviral activities of the ESP
are prominent in all methods, especially the first and the third method mentioned above.
Thus, we presume that this polysaccharide not only could extinguish the virus in Vero
cells, protect the Vero cells from attachment of virus, but also could execute the virus
effectively at a low concentration of 0.16~3.12
REFERENCES
[1] Gao Jinglian. Chinese Wild Plant (Zhongguo Yesheng Zhiwu), 1991 (2): 31-33.
[2] Carlucci M J, Ciancia M, Matulewicz M C et al. Antiviral Res., 1999, 43: 93-102.
[3] Kudi AC, Myint S H. J. Enthnopharmacol, 1999, 68 (1-3): 289-294.
[4] Kujumgiev A, Tsvetkova I, Serkedjieva Y et al. J. Enthnopharmacol, 1999, 64 (3):
235-240.
[5] Huang Zhengxiang. Fundamental Medicinal Virology and Experiments (Yixue bingduxue
jichu ji shiyan jishu). Beijing: Science Publishing House. 1990: 819-821.
[6] Martnez C M, Luks-Galger D B. Ann Pharmacother., 1997, 31(12): 1519-1521.
[7] Du Ping, Zhu Guanfu, Liu Xiangyun. Modern Clinical Virology (Xiandai linchuang
bingduxue). Beijing: People's Military Surgeon Publishing House. 1991: 582.